Dr. Kathleen J. Yost
Claim this profileBronson Methodist Hospital
Expert in Cancer
Expert in Tumors
223 reported clinical trials
339 drugs studied
Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Tumors
Global LeaderStage IV
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Kathleen J. Yost is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
More about Kathleen J. Yost
Clinical Trial Related7 years of experience running clinical trials · Led 223 trials as a Principal Investigator · 112 Active Clinical TrialsTreatments Kathleen J. Yost has experience with
- Nivolumab
- Cisplatin
- Carboplatin
- Radiation Therapy
- Pembrolizumab
- Cyclophosphamide
Breakdown of trials Kathleen J. Yost has run
Cancer
Tumors
Breast Cancer
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kathleen J. Yost specialize in?
Kathleen J. Yost focuses on Cancer and Tumors. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Kathleen J. Yost currently recruiting for clinical trials?
Yes, Kathleen J. Yost is currently recruiting for 103 clinical trials in Kalamazoo Michigan. If you're interested in participating, you should apply.
Are there any treatments that Kathleen J. Yost has studied deeply?
Yes, Kathleen J. Yost has studied treatments such as Nivolumab, Cisplatin, Carboplatin.
What is the best way to schedule an appointment with Kathleen J. Yost?
Apply for one of the trials that Kathleen J. Yost is conducting.
What is the office address of Kathleen J. Yost?
The office of Kathleen J. Yost is located at: Bronson Methodist Hospital, Kalamazoo, Michigan 49007 United States. This is the address for their practice at the Bronson Methodist Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.